The New York Entrepreneur

: Perrigo’s stock soars 6% after FDA approves its over-the-counter daily oral contraceptive

Read Time:26 Second

Perrigo Co. PLC’s stock PRGO soared 6% in premarket trade Thursday, after the company said the U.S. Food and Drug Administration has approved its over-the-counter daily oral contraceptive. The move was expected after an FDA advisory panel voted overwhelmingly in favor of the pill called opill, which is the first OTC contraceptive to be approved in the U.S.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post : Amazon saw its best sales performance ever on first day of Prime Day
Next post : SEC sues Celsius founder Alex Mashinsky for ‘fraudulent’ crypto sales